View of GLP-1 RECEPTOR AGONISTS AS A BREAKTHROUGH THERAPY FOR OBESITY AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW OF EFFICACY AND LONG-TERM OUTCOMES

Return to Article Details GLP-1 RECEPTOR AGONISTS AS A BREAKTHROUGH THERAPY FOR OBESITY AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW OF EFFICACY AND LONG-TERM OUTCOMES Download Download PDF